Home » Authors » Anette Breindl

Articles by Anette Breindl

In Neurons, Consequences Of Aneuploidy Get Another Look

April 28, 2005

By Anette Breindl

SSRIs Are Selective, But Affected Neurons Are Not

April 26, 2005

By Anette Breindl

SSRIs Are Selective, But Affected Neurons Are Not

April 26, 2005

By Anette Breindl

Novel Approach To Synthesis Causing Tetracycline Variety

April 25, 2005

By Anette Breindl

Novel Approach To Synthesis Causing Tetracycline Variety

April 25, 2005

By Anette Breindl

Autophagy Goes From Good To Bad In Neurodegeneration

April 22, 2005

By Anette Breindl

Autophagy Goes From Good To Bad In Neurodegeneration

April 22, 2005

By Anette Breindl

Probing Bonds Between Symptoms, Mechanisms

April 20, 2005

By Anette Breindl

Using ‘glue’ for herding cats provides therapeutic insights

April 20, 2005

By Anette Breindl

Probing Bonds Between Symptoms, Mechanisms

April 20, 2005

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...